Amgen
Institution Profile
Recognized for Excellence As a Med Honors Top Pharmaceutical Innovator, Amgen has been a pioneer in biotechnology since its founding in 1980. The company focuses on developing therapies for serious illnesses, with significant contributions in oncology and cardiovascular diseases. Amgen's commitment to advancing biologic treatments has led to innovative solutions that have improved patient outcomes worldwide. In oncology, Amgen is dedicated to delivering new therapies to patients with complex cancers. The company is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer. In the realm of cardiovascular diseases, Amgen has set a bold ambition to halve cardiovascular events in the U.S. by 2030, focusing on lowering LDL cholesterol levels to reduce the risk of heart attack and stroke. Amgen's dedication to scientific excellence and patient-centric innovation solidifies its position as a leader in the pharmaceutical industry.
Profile last updated: July 9, 2026
2026 TOP PHARMACEUTICAL INNOVATORS
Amgen
Also Featured



